TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Greenlight Capital Re Ltd (GLRE)

Financial Services Insurance - Reinsurance
16.70 $
+0.0% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

symbol.quality_heading

Open questions

The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.

Yellow, because substance and structure contradict each other. Green is ruled out by the lack of standalone operating strength: in both of the last two years the result was carried mainly by the securities portfolio — $60.2 million against $35.7 million in 2025, $79.6 million against minus $8.2 million in 2024 — and that portfolio is managed by an entity of the chairman of the board on hedge fund terms for most recently $10.9 million a year. Add reserve strengthening on prior-year claims of $11.4 million and $21.8 million, plus buybacks of which a third has gone directly to a family trust of the chairman since 01.06.2026. Red is ruled out by the absence of any substance finding: equity rose $72.1 million to $708.0 million during 2025, book value per share grew 13.8 percent, the loans are repaid, the combined ratio sits below 100 percent, and A.M. Best raised its rating to A (Excellent). This is a judgment on the company, not on the share price. The decision is yours.

symbol.quality_note

Read the Full Deep Dive
Greenlight Re: A Reinsurer Whose Profit Is Made in the Portfolio

Greenlight Capital Re shows up in our cash flow ranking at a ratio of 2.19 — a metric that simply measures the wrong thing at a reinsurer: the cash inflow consists largely of premiums set aside as reserves for claims still to come. We work that through, separate underwriting from investment results, and look at what having the portfolio run by an entity of the chairman of the board costs every year.

Read the analysis

Stock Watch

This analysis is as of July 27, 2026. Stock Watch will tell you what's changed at GLRE since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 6 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Trading Day

Previous Close
16.70$
Open
16.60$
Day High
16.70$
Day Low
16.30$
Volume
114,261shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
12.00 $ 19.00 $
11/04/2025 04/24/2026

Current price 16.70 $ — 67% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
0.5$B
Shares Outstanding
33Mio.
Float
75.0%
Beta
0.3

Performance

Perf. 1M
4.80%
Perf. 3M
-0.60%
Perf. 6M
13.80%
YTD Performance (%)
12.80%
52-Week-High Distance
-17.1%
Perf. 1Y
28.08%
Perf. 3Y
61.96%
Perf. 5Y
89.20%
Perf. 10Y
-19.29%
Perf. Since Inception
-30.71%

Technical Indicators

MA 38 Days
16.50$
MA 50 Days
16.40$
MA 200 Days
15.20$
RSI (14)
49.3
Volatility 30 Days
35.8%
Volatility 250 Days
26.4%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
7.4
Forward P/E
4.6
PEG
1.7
P/B
0.8
P/S
0.8
EV/EBITDA
0.0
Price/FCF
2.3

Profitability

Gross Margin
15.6%
EBIT Margin
Net Margin
11.5%
Return on Equity
11.5%
Return on Assets
2.5%

Balance Sheet & Safety

Equity Ratio
Debt/Equity
0.01
Altman Z″
4.13
Piotroski
7 out of 9

Growth

Sales Growth Last Quarter
-6.90%
EPS Growth Last Quarter
22.10%
Sales Growth (Year)
7.47%
Forward Sales Growth
Forward EPS Growth
-15.80%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
2
RS Rating
49
EPS Rating
67
Piotroski
7 out of 9
Fundamental Rating
D (43 out of 100)
Altman Z″
4.13

AI Rating

Neutral

Greenlight Re verkauft keine KI-Funktionen und weist keinen KI-Umsatz aus: In sechs geprüften Berichten (zwei Geschäftsberichte, vier Quartalsberichte) kommt künstliche Intelligenz ausschließlich im Geschäftsbericht 2025 vor — als interne Nutzungsrichtlinie und als Verstärker des Cyberrisikos; im jüngsten Quartalsbericht zum 31.03.2026 fällt der Begriff kein einziges Mal. Kein Produkt, kein Segment und keine Umsatzangabe ist mit KI verknüpft.

View the full file — quotes, sources, reviewed filings
„We are also monitoring use and potential uses of artificial intelligence (AI) tools across our business, and recently implemented an AI Usage Policy in order to establish guidelines for the ethical, secure, and compliant use of AI platforms by our employees"

Wir beobachten außerdem den Einsatz und mögliche Einsatzfelder von Werkzeugen der künstlichen Intelligenz in unserem gesamten Geschäft und haben kürzlich eine KI-Nutzungsrichtlinie eingeführt, um Leitlinien für den ethischen, sicheren und regelkonformen Umgang unserer Mitarbeiter mit KI-Plattformen festzulegen

10-K · 2026-03-09 · View SEC filing
„In addition, artificial intelligence technologies are evolving at a fast pace and being adopted, which may increase potential cybersecurity risks."

Zudem entwickeln sich Technologien der künstlichen Intelligenz rasch weiter und werden zunehmend eingesetzt, was potenzielle Cybersicherheitsrisiken erhöhen kann.

10-K · 2026-03-09 · View SEC filing

Filings Reviewed: 10-Q 2026-05-05 · 10-K 2026-03-09 · 10-Q 2025-11-03 · 10-Q 2025-08-04 · 10-Q 2025-05-07 · 10-K 2025-03-10

Rated on July 27, 2026 · How the Rating Is Built

Analysts & Price Target

Current Price 16.70 $
Price Target (average) 1.00 $

The price target sits 94.0% below the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

3. Aug 2026 · after the close · Q2 2026

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 136.2 $M Q4 2025: Q1 · 179.6 $M Q1 2025: Q2 · 178.4 $M Q2 2025: Q3 · 160.5 $M Q3 2025: Q4 · 177.9 $M Q4 2026: Q1 · 160.9 $M Q1

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.81 -262.60 136 -11.90 -20.10 30 30
2025: Q1 0.86 10.40 180 6.90 16.50 10 10
2025: Q2 0.01 -95.80 178 4.60 0.20 68 68
2025: Q3 -0.13 -112.90 161 -4.60 -2.70 31 31
2025: Q4 1.43 178 30.60 27.70 100 100
2026: Q1 1.05 21.50 161 -10.40 22.20 37 37
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 588 47 45 1.20 -36 874 2,665
2017 646 -45 -45 -1.21 94 851 3,357
2018 244 -354 -350 -9.74 -59 477 1,435
2019 491 -4 -4 -0.11 2 477 1,355
2020 479 4 4 0.11 -91 465 1,358
2021 570 21 18 0.51 -56 476 1,427
2022 478 25 25 0.64 -32 503 1,580
2023 632 87 87 2.50 8 596 1,735
2024 648 44 43 1.24 112 636 2,016
2025 696 78 75 2.17 210 708 2,170

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Assessment: Opportunities & Risks

Underwriting

The combined ratio fell to 94.6 percent in 2025 from 101.4 percent, and to 96.0 from 104.6 percent in the first quarter of 2026. A loss of $8.2 million turned into income of $35.7 million. Gross premiums rose 10.7 percent to $773.3 million, and A.M. Best raised its rating to A (Excellent).

Dependence on the portfolio

Investment income contributed $60.2 million to the 2025 result against $35.7 million from underwriting; in 2024, at $79.6 million, it was the only positive contribution. The group is contractually obliged to place substantially all of its investable assets in a single fund.

Conflict of interest and fees

The fund is managed by an entity of the chairman of the board on hedge fund terms: a 1.5 percent management fee and a 20 percent performance allocation, currently reduced to 10 percent. That cost $10.9 million in 2025, after $9.8 million and $8.0 million in the prior years. On top of that, since 01.06.2026 the company buys a third of every buyback directly from a family trust of the chairman.

Balance sheet and capital

Equity rose $72.1 million during 2025 to $708.0 million. The loans were fully repaid; only $5.0 million on a credit facility was outstanding at 31.12.2025, and interest coverage stood at roughly 19 times. The Altman insolvency early-warning score is deliberately not used here — the formula was not built for insurers.

Reserves

Re-estimating prior-year claims cost $11.4 million in 2025 and $21.8 million in 2024 — considerable against underwriting income of $35.7 million in 2025. In the first quarter of 2026 the line turned positive for the first time, at a gain of $1.6 million.

Hook and data quality

47th of 545 U.S. hits in the in-house P/FCF ranking at 2.19, measured identically on both editions on 27.07.2026 — outside the 25 rows displayed and visible only through the screener or the company page. The metric itself is not used for valuation in this article: at an insurer it measures premiums collected that are future obligations. The market value carried in the data set, $0.518 billion, sits roughly 8 percent below our own calculation from the cover page share count and the price ($564 million).

Bottom Line

Greenlight Capital Re is two businesses in one share: a reinsurer that earns again after weak years — combined ratio 94.6 percent after 101.4 — and a securities portfolio that contributed $60.2 million to the 2025 result against $35.7 million from underwriting. That portfolio is managed by an entity of the chairman of the board, which received $10.9 million for it. The metric that put the name on our list measures nothing distributable at an insurer; the fitting measure is book value per share, and there the stock trades at 0.79 times. Not investment advice.

Worth Noting:
  • Hook and source: 47th of 545 U.S. hits in the in-house P/FCF ranking at a value of 2.19, measured live on July 27, 2026 and identical on both editions; the German list covering all markets counted 836 hits the same day. Only the 25 strongest rows are displayed — Greenlight Re is not among them and has to be found through the screener or the company page. The lists are recalculated daily.
  • Why the hook metric is not used for valuation in the article: at a reinsurer, operating cash flow consists largely of premiums for claims not yet paid. Of $210.2 million in 2025, $107.0 million came from the increase in loss reserves and $37.2 million from higher unearned premiums. Used instead is the price-to-book ratio, which the company itself names as its guiding measure.
  • Why we calculated the market value ourselves: the value carried in the data set, $0.518 billion, sits roughly 8 percent below the calculation from the share count on the 10-Q cover page (33,166,448 as of 30.04.2026) and the closing price of $16.99 on 24.07.2026, which gives $564 million.
  • On the Altman score: our data set carries a value of 4.13 for GLRE. It is deliberately not used as evidence in the article, because the formula was developed for industrial and trading companies and at insurers draws on quantities that are not comparable there. The argument runs instead on equity, investments, reserve development, combined ratio and interest coverage.
  • On the distance from the high: our data set shows 52.8 percent. Calculated ourselves from the price series we get 51.5 percent against the highest closing price of $35.00 on 04.09.2014. The article uses the self-calculated figure.
  • Status of the mandatory checks on July 27, 2026: the most recent periodic report is the quarterly report for March 31, 2026 (filed 05.05.2026). The filing record contains no tender offer, no merger, no going-private transaction, no Form 15 and no Form 25. Filed after the quarterly report were the current report 8-K of 01.06.2026 (Item 1.01), a Schedule 13D/A of the same day, and insider and sale notices; all have been reviewed.
  • Risk of confusion: Greenlight Capital Re, Ltd. (GLRE, Nasdaq) is the listed reinsurer. Greenlight Capital, Inc. and DME Advisors, LP are separate entities from the orbit of David Einhorn; they manage the portfolio but are not themselves listed.

About the Company

Greenlight Capital Re, Ltd. ist über seine Tochtergesellschaften weltweit ein Sach- und Schadenrückversicherungsunternehmen.

Employees84
HeadquartersGrand Cayman, Cayman Islands
Address65 Market Street, KY1-1205 Grand Cayman, Cayman Islands
Phone345 943 4573
Websitegreenlightre.com
IPO Date24. May 2007
ISINKYG4095J1094

Management

Management
Name Title Birth Year
Greg Richardson CEO & Director 1960
Faramarz Romer Chief Financial Officer 1977
Patrick O'Brien Chief Operating Officer 1970
Thomas James Curnock Ph.D. Group Chief Underwriting Officer 1972
Brian O'Reilly Head of Innovations 1985
Steven Archambault Chief Accounting Officer 1971
Adam Prior Senior Vice President of Equity Group Inc.
David E. Sigmon General Counsel, Corporate Secretary & Chief Compliance Officer 1984
Simon Burton Advisor 1970
Kagabo Ngiruwonsanga Head of Innovation Underwriting

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?